Taiwan's leading probiotic manufacturer SYNBIO TECH INC. won six awards at the 2025 Tokyo Innovation Genius International Invention Exhibition. Its outstanding R&D capabilities have not only brought the company significant recognition but also showcased the brilliance and strength of Taiwan's biotechnology on the international stage.

The company stated that five of its functional probiotic products—ABKEFIR, SynForU-ReMain, LDL557, FS4722, and BY2—were all awarded gold medals, demonstrating its technological depth in precision nutrition and gut microbiome fields. Among these, the postbiotic formula LDL557, developed specifically for joint health, stood out for its innovation and application potential, earning the highest honor of the exhibition, the "Special Award."

The company pointed out that Japan, as the second-largest health food market in the world, has always scrutinized the technological content and clinical potential of functional ingredients with high standards. Shenghe Biotechnology's ability to stand out among global competitors not only highlights its R&D strength in product translation and clinical applications but also further solidifies its professional position in the Asian probiotic market.

SYNBIO TECH INC. has long been committed to the precise application of probiotics and postbiotics. Currently, it focuses on important health issues such as sports nutrition, healthy aging, gut health, and joint health, continuously advancing the innovative development of functional ingredients through patented technology, experimental validation, and international exchanges.